Neuroscience News

The amount of a neurotransmitter called GABA in the dorsolateral prefrontal cortex predicted individuals’ ability to keep several things in mind simultaneously, researchers found.

The Society for Neuroscience (SfN) will award the Julius Axelrod Prize to Robert Malenka, MD, PhD, of Stanford University School of Medicine. The Julius Axelrod Prize recognizes exceptional achievements in neuropharmacology or a related field and exemplar

The Society for Neuroscience (SfN) will present its highest award, the Ralph W. Gerard Prize in Neuroscience, to Ben Barres, PhD, of Stanford University, and Thomas Jessell, PhD, of Columbia University.

Tom Stoppard’s latest play, which tackles issues of neuroscience and consciousness – leading to its title, “The Hard Problem” – was followed by a panel discussion with scientists from Stanford and the University of California, Berkeley.

Congratulations are in order for entrepreneur/philanthropist Sean Parker, founder of the Parker Foundation; Ann Arvin, MD, who has dedicated her career to understanding infectious diseases in children; and attorney John Levin, chair of the Stanford Health

Nothing prevents great researchers from having great personalities.

Theo Palmer, associate professor of neurosurgery, has long sought to understand how genetic and environmental factors collide to shape brain function.

Stanford neuroscientist Leanne Williams, PhD, has focused her research career on how insights from brain science can help improve care for people with psychiatric conditions.

Big pharmaceutical companies have gradually abandoned their one time obsession with ridding Alzheimer’s patients’ brains of gummy extracellular deposits known as amyloid plaques (they’re composed of a protein called beta-amyloid) that characterize the dis

Stanford Neurosciences Institute member Xiaoke Chen is first recipient of the Firmenich Next Generation Fund to support his work to study the way our body's sense of self motivates behavior.

The Stanford recipients are among 88 scientists nationwide to receive Pioneer, New Innovator, Transformative Research and Early Independence awards through the NIH’s High-Risk, High-Reward program. The awards total about $127 million and are supported by

A look at where research stands on some of the most devastating brain diseases.

Technology for reading signals directly from the brain developed by Stanford Bio-X scientists could provide a way for people with movement disorders to communicate.

Engineer Krishna Shenoy, PhD, and graduate student (and then postdoctoral fellow) Paul Nuyujukian, MD, PhD, have updated the algorithms for how they translate the brain signals into typing, which they tested in a series of studies.

We discovered that this impairment in regulation of Miro may actually underlie both familial (inherited) and sporadic (not inherited, or unknown family tree) forms of Parkinson’s disease.

Intracellular defects that lead to cells’ failure to decommission faulty “power packs” known as mitochondria cause nerve cells to die, triggering the symptoms of Parkinson’s disease.